Tom Brassington

Tom Brassington

Partner Corporate & Finance

London

+44 20 7296 5589

[email protected]

Languages

English

Tom Brassington

Overview
Experience
Credentials
Insights and events

'commercial in his attitude, view and outlook.'
Chambers UK

Tom Brassington is a senior partner in the firm's London Corporate & Finance practice group.

He is ranked in Chambers Global for Corporate/M&A, with his expertise in international and cross-border M&A highlighted in particular.

He has experience across a wide variety of work including public and private M&A, joint ventures, restructurings, private equity, and equity capital markets. While Tom is a generalist M&A practitioner, he regularly acts for clients in the Life Sciences and Technology, Media & Telecoms sectors.

While Tom is based in London, he has also practiced in both Dubai and Hong Kong.

'commercial in his attitude, view and outlook.'
Chambers UK

Representative experience

Advising McCormick & Company on its $45 billion acquisition of the Unilever Foods business

Advising the UK government on the takeover of International Distribution Services plc, the parent company of Royal Mail, by the EP Group

Advising Novartis on the sale of Advanced Accelerator Applications Molecular Imaging to Siemens Healthineers

Advising Revvity, Inc. on the sale of its applied, food and enterprise services businesses to New Mountain Capital

Advising PerkinElmer, Inc. on public takeover offers for each Horizon Discovery Group plc, Oxford Immunotec Global plc and Immunodiagnostic Systems Holdings plc

Advising Novartis Institutes for Biomedical Research (NIBR) on its acquisition of Arctos Medical

Advising Sandoz AG on the acquisition of the worldwide product rights for Mycamine®, an antifungal agent, from Astellas Pharma Inc

Advising Smiths Group plc on the acquisitions of Seebach GmbH and United Flexible, Inc and its investment in Ivenix, Inc

Advising Google on a variety of corporate transactions in the UK

Advising The British Council on the sale of its IELTS business in India to IDP Education Limited

Advising The Anschutz Corporation in respect of the US$5.8bn acquisition of Regal Entertainment Group by Cineworld Group plc

Advising Recordati on its US$300m acquisition of the European commercial rights to AstraZeneca's blood pressure and heart failure products, Seloken, Seloken ZOK and Logimax

Advising McCormick & Co. on its takeover offer for Premier Foods plc

Advising News Corporation on various transactions including the acquisitions of Shine and Unruly

Advising Electra Private Equity PLC on the demerger of Hostmore plc onto the London Stock Exchange

Advising Lockheed Martin on various transactions, including the separation and combination of its IT and technical services businesses with Leidos

Advising Intrexon Corporation on the acquisition of Oxitec Ltd., a pioneer in biological insect control solutions

Advising Jazz Pharmaceuticals PLC on the sale of a portfolio of pharmaceutical products and medical devices to Essex Woodlands Fund IX L.P

Advising Kingfisher PLC on the sale of its controlling stake in B&Q China to Beijing-based Wumei Holdings

Advising Johnson and Johnson on transactions including acquisitions of Spectrum Vision; OTC brands of JB Chemicals & Pharmaceuticals Limited; and Finsbury Orthopaedics on business disposal